Randomized Controlled Study of the Effectiveness of IV Fluid Infusion in Patients With Acute Ischemic Stroke (IVIS)
NCT02003794 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2015-08-04
Summary
To study the result of intravenous fluid in patients with acute ischemic stroke within 72 hours.
Conditions
Interventions
- DRUG
-
0.9% NaCl solution
0.9% NaCl solution intravenous infusion: 100 ml/hr for three days.
Sponsors & Collaborators
-
National Research Council of Thailand
collaborator OTHER_GOV -
Chulalongkorn University
lead OTHER
Principal Investigators
-
Nijasri C Suwanwela, MD · Chulalongkorn University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2015-01-31
- Completion
- 2015-01-31
Countries
- Thailand
Study Locations
More Related Trials
-
Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China(IVTIS)
NCT06131385 ·Status: RECRUITING
-
Single Ascending Dose Safety and Tolerability of NTS-104 Healthy Adults
NCT05547438 ·Status: UNKNOWN ·Phase: PHASE1
-
Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
NCT06841965 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)
NCT02002325 ·Status: UNKNOWN ·Phase: PHASE3
-
Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke
NCT04674293 ·Status: UNKNOWN
-
Efficacy and Safety of Early Initiation of Butylphthalide Treatment in Patients With Acute Ischemic Stroke.
NCT06472921 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)
NCT01273467 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Intravenous Tissue-type Plasminogen Activator on Acute Ischemic Stroke Patients With Large Vessel Occlusions
NCT04170647 ·Status: UNKNOWN
-
Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy
NCT04693715 ·Status: COMPLETED ·Phase: PHASE2
-
Endovascular Therapy for Acute Ischemic Stroke Trial
NCT02350283 ·Status: COMPLETED ·Phase: PHASE3
-
Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window
NCT05634382 ·Status: UNKNOWN ·Phase: PHASE3
-
The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke
NCT00868283 ·Status: COMPLETED ·Phase: PHASE4
-
24 Hours Treatment with Alteplase in Patients with Ischemic Stroke
NCT04879615 ·Status: COMPLETED ·Phase: PHASE3
-
Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007-2017: Analysis of China National Stroke Registry (CNSR) I, II, and III; CTP-Draft Review Performed;
NCT04290494 ·Status: COMPLETED
-
The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018)
NCT00401310 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of BIIB131 for Participants With Ischemic Stroke Between 4.5 and 24 Hours After Last Known Well
NCT05764122 ·Status: WITHDRAWN ·Phase: PHASE2
-
Intra-Arterial Neuroprotective Agents and Cold Saline in Ischemic Stroke Intervention
NCT05032781 ·Status: WITHDRAWN ·Phase: PHASE1
-
Acute Ischemic Stroke Interventional Study
NCT03803007 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
NCT06781385 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Exploratory Study on the Effects of Early Rosuvastatin Treatment in Patients With Acute Ischemic Stroke
NCT02643784 ·Status: UNKNOWN ·Phase: PHASE4
-
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
NCT05691244 ·Status: RECRUITING ·Phase: PHASE3
-
Study Evaluating Single Ascending Doses Of ILS-920
NCT00827190 ·Status: COMPLETED ·Phase: PHASE1
-
Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS)
NCT00540527 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Intranasal Nerve Growth Factor for Acute Ischemic Stroke
NCT03686163 ·Status: COMPLETED ·Phase: PHASE4
-
Intra-arterial Tenecteplase During First Thrombectomy Attempt for Acute Stroke (BRETIS-TNK II)
NCT05657444 ·Status: COMPLETED ·Phase: PHASE3